Reducible poly(amido ethylenimine) directed to enhance RNA interference

被引:151
作者
Jeong, Ji Hoon
Christensen, Lane V.
Yockman, James W.
Zhong, Zhiyuan
Engbersen, Johan F. J.
Kim, Won Jong
Feijen, Jan
Kim, Sung Wan [1 ]
机构
[1] Univ Utah, CCCD, Dept Pharmaceut & Pharmaceut Chem, Salt Lake City, UT 84112 USA
[2] Univ Twente, Fac Sci & Technol, Dept Polymer Chem & Biomat, NL-7500 AE Enschede, Netherlands
[3] Univ Twente, Fac Sci & Technol, Inst Biomed Technol, NL-7500 AE Enschede, Netherlands
关键词
poly(amido ethylenimine); siRNA; reducible polymer; non-viral gene delivery;
D O I
10.1016/j.biomaterials.2006.12.019
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Designing synthetic macromolecular vehicles with high transfection efficiency and low cytotoxicity has been a major interest in the development of non-viral gene carriers. A reducible poly(amido ethylenimine) (SS-PAEI) synthesized by addition copolymerization of triethylenetetramine and cystamine bis-acrylamide (poly(TETA/CBA)) was used as a carrier for small interference RNA (siRNA). Poly(TETA/CBA) could efficiently condense siRNA to form stable complexes under physiological conditions and perform complete release of siRNA in a reductive environment. When formulated with VEGF-directed siRNA, poly(TETA/CBA) demonstrated significantly higher suppression of VEGF than linear-polyethylenimine (PEI) (L-PEI, 25 kDa) in human prostate cancer cells (PC-3). After 5 h of transfection, substantial dissociation and intracellular distribution of siRNA was observed in the poly(TETA/CBA) formulation, but not in the L-PEI formulation. The triggered release of siRNA by reductive degradation of poly(TETA/CBA) in the cytoplasm may affect the RNAi activity by increasing cytoplasmic availability of siRNA. These results suggest that the rational design of non-viral carriers should involve considerations for intracellular dissociation and trafficking of a nucleic acid drug to maximize its effect, in conjunction with formation of stable complexes under physiological conditions. (c) 2006 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1912 / 1917
页数:6
相关论文
共 25 条
[11]   DNA transfection using linear poly(ethylenimine) prepared by controlled acid hydrolysis of poly(2-ethyl-2-oxazoline) [J].
Jeong, JH ;
Song, SH ;
Lim, DW ;
Lee, H ;
Park, TG .
JOURNAL OF CONTROLLED RELEASE, 2001, 73 (2-3) :391-399
[12]   Target-specific gene silencing by siRNA plasmid DNA complexed with folate-modified poly(ethylenimine) [J].
Kim, SH ;
Jeong, JH ;
Cho, KC ;
Kim, SW ;
Park, TG .
JOURNAL OF CONTROLLED RELEASE, 2005, 104 (01) :223-232
[13]   Interfering with disease: opportunities and roadblocks to harnessing RNA interference [J].
Lieberman, J ;
Song, E ;
Lee, SK ;
Shankar, P .
TRENDS IN MOLECULAR MEDICINE, 2003, 9 (09) :397-403
[14]   Gene silencing in mammals by small interfering RNAs [J].
McManus, MT ;
Sharp, PA .
NATURE REVIEWS GENETICS, 2002, 3 (10) :737-747
[15]   Block catiomer polyplexes with regulated densities of charge and disulfide cross-linking directed to enhance gene expression [J].
Miyata, K ;
Kakizawa, Y ;
Nishiyama, N ;
Harada, A ;
Yamasaki, Y ;
Koyama, H ;
Kataoka, K .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2004, 126 (08) :2355-2361
[17]   Lactosylated poly(ethylene glycol)-siRNA conjugate through acid-labile ß-thiopropionate linkage to construct pH-sensitive polyion complex micelles achieving enhanced gene silencing in hepatoma cells [J].
Oishi, M ;
Nagasaki, Y ;
Itaka, K ;
Nishiyama, N ;
Kataoka, K .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2005, 127 (06) :1624-1625
[18]   Laterally stabilized complexes of DNA with linear reducible polycations: Strategy for triggered intracellular activation of DNA delivery vectors [J].
Oupicky, D ;
Parker, AL ;
Seymour, LW .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2002, 124 (01) :8-9
[19]   A versatile reducible polycation-based system for efficient delivery of a broad range of nucleic acids [J].
Read, ML ;
Singh, S ;
Ahmed, Z ;
Stevenson, M ;
Briggs, SS ;
Oupicky, D ;
Barrett, LB ;
Spice, R ;
Kendall, M ;
Berry, M ;
Preece, JA ;
Logan, A ;
Seymour, LW .
NUCLEIC ACIDS RESEARCH, 2005, 33 (09) :1-16
[20]   Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity [J].
Shiver, JW ;
Fu, TM ;
Chen, L ;
Casimiro, DR ;
Davies, ME ;
Evans, RK ;
Zhang, ZQ ;
Simon, AJ ;
Trigona, WL ;
Dubey, SA ;
Huang, LY ;
Harris, VA ;
Long, RS ;
Liang, XP ;
Handt, L ;
Schleif, WA ;
Zhu, L ;
Freed, DC ;
Persaud, NV ;
Guan, L ;
Punt, KS ;
Tang, A ;
Chen, MC ;
Wilson, KA ;
Collins, KB ;
Heidecker, GJ ;
Fernandez, VR ;
Perry, HC ;
Joyce, JG ;
Grimm, KM ;
Cook, JC ;
Keller, PM ;
Kresock, DS ;
Mach, H ;
Troutman, RD ;
Isopi, LA ;
Williams, DM ;
Xu, Z ;
Bohannon, KE ;
Volkin, DB ;
Montefiori, DC ;
Miura, A ;
Krivulka, GR ;
Lifton, MA ;
Kuroda, MJ ;
Schmitz, JE ;
Letvin, NL ;
Caulfield, MJ ;
Bett, AJ ;
Youil, R .
NATURE, 2002, 415 (6869) :331-335